Most peptide profiles describe a sequence. Thymulin's profile has to describe a sequence and a metal ion, because the published work says the peptide is active only with zinc attached. That detail changes how it should be sourced, documented and handled.
What Thymulin Is
Thymulin is a nonapeptide produced by thymic epithelial cells. It was earlier called serum thymic factor (FTS, from the French facteur thymique sérique), initially isolated from porcine serum and shown to be present in calf thymus extract, according to a 1994 review by Dardenne and Pleau.
| Property | Value |
|---|---|
| Sequence | pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn |
| Length | 9 residues, with an N-terminal pyroglutamate |
| Approximate mass (peptide alone) | about 859 Da (our calculation from the sequence) |
| Former name | serum thymic factor (FTS) |
| Metal requirement | zinc, reported in a 1:1 ratio with the peptide |
Zinc Is Part of the Structure
Several papers establish the link between the peptide and zinc:
- Activity. The 1985 paper by Dardenne and colleagues describes thymulin's biological activity as strictly dependent on zinc in the molecule.
- Antibodies. In the same paper, two monoclonal antibodies recognized only the zinc-bound form, while antibodies screened with a zinc-free substrate recognized a zinc-independent epitope. The authors concluded that a zinc-specific conformation exists.
- Free peptide. Laussac and colleagues (1986) studied the free peptide by NMR. In aqueous solution, their data fit a mobile equilibrium among several conformations. In dimethyl sulfoxide, a more rigid structure with three internal hydrogen bonds appeared.
- Zinc complexes. Cung and colleagues (1988) found two kinds of Zn(II) complex in solution by NMR: a species with two peptide molecules per zinc ion, which predominates when metal is below one equivalent, and a 1:1 species. They assigned the zinc ligands in each, and reported that the 1:1 complex is the only form recognized by the antibodies.
- Where it comes from. Dardenne and Pleau (1994) note that zinc and metallothionein have been demonstrated in the thymic epithelial cells that produce the peptide, and that this suggests the molecule is secreted already carrying zinc.
Other Published Directions
A 2014 review by Reggiani and colleagues describes thymulin as produced by thymic epithelial cells, under neuroendocrine influence, and discusses a synthetic analog, metFTS, that has been used in experimental systems. Those studies are in animal models and expression systems. They are not evidence of any effect in people.
What This Means at the Bench
- The peptide and the complex are different species. A bioassay and an assay that uses a zinc-free reagent can give different answers, as the 1985 antibody work shows.
- Zinc ratio. Experiments that depend on activity should record how zinc was supplied and in what ratio to the peptide.
- Solvent matters for structure. The NMR work shows that conformation depends on the solvent.
If You Source This Compound for Research
- Ask whether the product is the peptide alone or a zinc complex, and how this is documented.
- Request an analytical report with mass, purity and, if zinc is claimed, an elemental or metal-content measurement.
- Confirm the N-terminal pyroglutamate. A free glutamine or glutamic acid at that position is a different molecule.
- Store lyophilized material cold, dry and away from light. See Storing Lyophilized Peptides in the Lab and How to Read a Peptide Analytical Report.
FAQ
Is thymulin the same as serum thymic factor? Yes. The literature uses both names, plus FTS.
Why does a nine-residue peptide need a metal? The NMR studies describe zinc coordinated by side-chain and carboxylate groups of the peptide, giving a defined conformation.
Does the sequence alone define the product? Not on the published evidence. Metal content is part of the identity.
Sources
- Dardenne M et al. Proceedings of the National Academy of Sciences, 1985. PubMed 2413455: https://pubmed.ncbi.nlm.nih.gov/2413455/
- Laussac JP et al. Journal of Biological Chemistry, 1986. PubMed 3711109: https://pubmed.ncbi.nlm.nih.gov/3711109/
- Cung MT et al. Journal of Biological Chemistry, 1988. PubMed 3356698: https://pubmed.ncbi.nlm.nih.gov/3356698/
- Dardenne M, Pleau JM. Metal-Based Drugs, 1994. PubMed 18476235: https://pubmed.ncbi.nlm.nih.gov/18476235/
- Reggiani PC et al. Current Pharmaceutical Design, 2014. PubMed 24588820: https://pubmed.ncbi.nlm.nih.gov/24588820/
Every Peptide Privé batch is tested by an independent lab.
Contact our team with documentation questions.
For in-vitro laboratory research only. Not for human or animal use.
